It has been proposed that the “telomeres” of the chromosomes, their four endpoints, determine our future: Harbingers of mortality, the telomeres at the chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner. However, the utilization of telomeres in clinical practice for patient evaluation is still in the distant future. At the present time, we can report that substantial advances have recently been achieved with the applications of molecular imaging (MI) in the evaluation of oncologic patients.